A test that can diagnose either influenza or COVID-19 from a single patient sample has won marketing authorization from the US Food and Drug Administration.
The test, which was developed by the Centers for Disease Control and Prevention (CDC), is the third diagnostic that can differentiate between the two diseases to be granted an emergency...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?